Literature DB >> 15064735

Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice.

Elena A Komarova1, Roman V Kondratov, Kaihua Wang, Konstantin Christov, Tatiana V Golovkina, John R Goldblum, Andrei V Gudkov.   

Abstract

Ionizing radiation (IR) induces p53-dependent apoptosis in radiosensitive tissues, suggesting that p53 is a determinant of radiation syndromes. In fact, p53-deficient mice survive doses of IR that cause lethal hematopoietic syndrome in wild-type animals. Surprisingly, p53 deficiency results in sensitization of mice to higher doses of IR, causing lethal gastro-intestinal (GI) syndrome. While cells in the crypts of p53-wild-type epithelium undergo prolonged growth arrest after irradiation, continuous cell proliferation ongoing in p53-deficient epithelium correlates with accelerated death of damaged cells followed by rapid destruction of villi and accelerated lethality. p21-deficient mice are also characterized by increased sensitivity to GI syndrome-inducing doses of IR. We conclude that p53/p21-mediated growth arrest plays a protective role in the epithelium of small intestine after severe doses of IR. Pharmacological inhibition of p53 by a small molecule that can rescue from lethal hematopoietic syndrome has no effect on the lethality from gastro-intestinal syndrome, presumably because of a temporary and reversible nature of its action. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064735     DOI: 10.1038/sj.onc.1207494

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  106 in total

1.  p21 protects "Super p53" mice from the radiation-induced gastrointestinal syndrome.

Authors:  Julie M Sullivan; Laura B Jeffords; Chang-Lung Lee; Rafaela Rodrigues; Yan Ma; David G Kirsch
Journal:  Radiat Res       Date:  2011-12-13       Impact factor: 2.841

2.  Accelerated hematopoietic toxicity by high energy (56)Fe radiation.

Authors:  Kamal Datta; Shubhankar Suman; Daniela Trani; Kathryn Doiron; Jimmy A Rotolo; Bhaskar V S Kallakury; Richard Kolesnick; Michael F Cole; Albert J Fornace
Journal:  Int J Radiat Biol       Date:  2011-12-12       Impact factor: 2.694

3.  Activation of two distinct Sox9-EGFP-expressing intestinal stem cell populations during crypt regeneration after irradiation.

Authors:  Laurianne Van Landeghem; M Agostina Santoro; Adrienne E Krebs; Amanda T Mah; Jeffrey J Dehmer; Adam D Gracz; Brooks P Scull; Kirk McNaughton; Scott T Magness; P Kay Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-23       Impact factor: 4.052

4.  A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.

Authors:  Dinesh K Thotala; Ling Geng; Amy K Dickey; Dennis E Hallahan; Eugenia M Yazlovitskaya
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-01       Impact factor: 7.038

Review 5.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

Review 6.  Radiation enteropathy--pathogenesis, treatment and prevention.

Authors:  Martin Hauer-Jensen; James W Denham; H Jervoise N Andreyev
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-04-01       Impact factor: 46.802

7.  The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest.

Authors:  Katelyn M Atkins; Laura L Thomas; Jonathan Barroso-González; Laurel Thomas; Sylvain Auclair; Jun Yin; Hyeog Kang; Jay H Chung; Jimmy D Dikeakos; Gary Thomas
Journal:  Cell Rep       Date:  2014-08-21       Impact factor: 9.423

8.  Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents.

Authors:  Anastasia R Goloudina; Kan Tanoue; Arlette Hammann; Eric Fourmaux; Xavier Le Guezennec; Dmitry V Bulavin; Sharlyn J Mazur; Ettore Appella; Carmen Garrido; Oleg N Demidov
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

9.  G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.

Authors:  Gilles Doumont; Alain Martoriati; Chantal Beekman; Sven Bogaerts; Patrick J Mee; Fabrice Bureau; Emanuela Colombo; Myriam Alcalay; Eric Bellefroid; Francesco Marchesi; Eugenio Scanziani; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

10.  Regulation of ceramide synthase-mediated crypt epithelium apoptosis by DNA damage repair enzymes.

Authors:  Jimmy A Rotolo; Judith Mesicek; Jerzy Maj; Jean-Philip Truman; Adriana Haimovitz-Friedman; Richard Kolesnick; Zvi Fuks
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.